Related Articles Recommendations on intervention for hepatobiliary oncological surgery during the COVID 19 pandemic Cir Esp 2020 Dec 16 Authors Garc a Botella A G mez Bravo MA Di Martino M Gastaca M Mart n P rez E S nchez Cab s S S nchez P rez B L pez Ben S Rodr guez Sanju n JC L pez And jar R Barrera M Grupo colaborativo Cirug a AEC COVID 19 Grupo colaborativo Cirug a AEC COVID 19 Balibrea JM Rubio P rez I Badia JM Martin Antona E lvarez Pe a E Garcia Botella A Mart n P rez E lvarez Gallego M Mart nez Cortijo S Pascual Miguel ez I P rez D az L Ramos Rodr quez JL Esp n Basany E S nchez Santos R Guirao Garriga X Aranda Narv ez JM Morales Conde S Abstract The SARS CoV 2 COVID 19 pandemic requires an analysis in the field of oncological surgery both on the risk of infection with very relevant clinical consequences and on the need to generate plans to minimize the impact on possible restrictions on health resources The AEC is making a proposal for the management of patients with hepatopancreatobiliary HPB malignancies in the different pandemic scenarios in order to offer the maximum benefit to patients minimising the risks of COVID 19 infection and optimising the healthcare resources available at any time This requires the coordination of the different treatment options between the departments involved in the management of these patients medical oncology radiotherapy oncology surgery anaesthesia radiology endoscopy department and intensive care The goal is offer effective treatments adapted to the available resources without compromising patients and healthcare professionals safety PMID 33341242 PubMed as supplied by publisher